James Kinley - Net Worth and Insider Trading
James Kinley Net Worth
The estimated net worth of James Kinley is at least $25,797 dollars as of 2024-09-21. James Kinley is the Senior Officer of Algernon Pharmaceuticals Inc and owns about 303,492 shares of Algernon Pharmaceuticals Inc (XCNQ:AGN) stock worth over $25,797. Details can be seen in James Kinley's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James Kinley has not made any transactions after 2024-05-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of James Kinley
James Kinley Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James Kinley owns 1 companies in total, including Algernon Pharmaceuticals Inc (XCNQ:AGN) .
Click here to see the complete history of James Kinley’s form 4 insider trades.
Insider Ownership Summary of James Kinley
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| XCNQ:AGN | Algernon Pharmaceuticals Inc | 2024-05-16 | Senior Officer |
James Kinley Latest Holdings Summary
James Kinley currently owns a total of 1 stock. James Kinley owns 303,492 shares of Algernon Pharmaceuticals Inc (XCNQ:AGN) as of May 16, 2024, with a value of $25,797.
Latest Holdings of James Kinley
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| XCNQ:AGN | Algernon Pharmaceuticals Inc | 2024-05-16 | 303,492 | 0.09 | 25,797 |
Holding Weightings of James Kinley
James Kinley Form 4 Trading Tracker
According to the SEC Form 4 filings, James Kinley has made a total of 5 transactions in Algernon Pharmaceuticals Inc (XCNQ:AGN) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in Algernon Pharmaceuticals Inc is the acquisition of 12,500 shares on May 16, 2024, which cost James Kinley around $1,563.
Insider Trading History of James Kinley
- 1
James Kinley Trading Performance
GuruFocus tracks the stock performance after each of James Kinley's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James Kinley is -35.98%. GuruFocus also compares James Kinley's trading performance to market benchmark return within the same time period. The performance of stocks bought by James Kinley within 3 months outperforms 0 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James Kinley's insider trading performs compared to the benchmark.
Performance of James Kinley
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -13.9 | | | | | |
| Relative Return to S&P 500(%) | -8.6 | | | | | |
James Kinley Ownership Network
James Kinley Owned Company Details
What does Algernon Pharmaceuticals Inc do?
Who are the key executives at Algernon Pharmaceuticals Inc?
James Kinley is the Senior Officer of Algernon Pharmaceuticals Inc. Other key executives at Algernon Pharmaceuticals Inc include Director & Senior Officer Christopher Moreau , Senior Officer Christopher Scott Bryan , and Senior Officer Michael Sadhra .
Algernon Pharmaceuticals Inc (XCNQ:AGN) Insider Trades Summary
Over the past 18 months, James Kinley made 1 insider transaction in Algernon Pharmaceuticals Inc (XCNQ:AGN) with a net purchase of 12,500. Other recent insider transactions involving Algernon Pharmaceuticals Inc (XCNQ:AGN) include a net purchase of 60,500 shares made by Christopher Scott Bryan , a net purchase of 52,500 shares made by Christopher Moreau ,
In summary, during the past 3 months, insiders sold 0 shares of Algernon Pharmaceuticals Inc (XCNQ:AGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Algernon Pharmaceuticals Inc (XCNQ:AGN) were sold and 125,500 shares were bought by its insiders, resulting in a net purchase of 125,500 shares.
Algernon Pharmaceuticals Inc (XCNQ:AGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Algernon Pharmaceuticals Inc Insider Transactions
James Kinley Mailing Address
Above is the net worth, insider trading, and ownership report for James Kinley. Currently GuruFocus does not have mailing address information for James Kinley.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
